首页> 外文期刊>Endoscopy: Journal for Clinical Use Biopsy and Technique >Esophageal capsule endoscopy versus Esophagogastroduodenoscopy for evaluating portal hypertension: a prospective comparative study of performance and tolerance.
【24h】

Esophageal capsule endoscopy versus Esophagogastroduodenoscopy for evaluating portal hypertension: a prospective comparative study of performance and tolerance.

机译:食管胶囊内镜与食管胃十二指肠镜评估门脉高压:性能和耐受性的前瞻性比较研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND AND STUDY AIMS: Esophagogastroduodenoscopy (EGD) is the most effective method for examining the upper gastrointestinal tract, and particularly for evaluating portal hypertension in cirrhotic patients, especially for screening purposes. The aim of this study was to assess the feasibility, safety, accuracy, and tolerance of PillCam ESO capsule endoscopy for this indication. PATIENTS AND METHODS: In this prospective study, unsedated EGD and capsule endoscopy examinations were conducted on the same day in cirrhotic patients at the time of diagnosis. The patients quantified the tolerability (relative to pain, nausea, choking sensations, etc.) of the two procedures using a 100-mm visual analogue scale. The time required for the recording and for diagnosis with the capsule examination were documented, as were the patients' preferences in comparison with EGD. Two independent endoscopists blinded to the EGD diagnoses assessed the diagnostic accuracy of the images obtained. RESULTS: Twenty-one patients were included in the study (mean age 62, mean Model for End-Stage Liver Disease score 10.5, mean Child-Pugh score 7.3). The procedure was safe. One patient was unable to swallow the capsule. The mean recording time was 213 s (range 6 - 1200 s); the procedure accurately assessed the presence or absence of esophageal varices in 16 of 19 patients (84.2 %); and it correctly indicated a need for primary prophylaxis (esophageal varices of grade 2 or more and/or red signs) in 100 % of cases. The tolerability of the capsule endoscopy examination was significantly better, and all of the patients preferred capsule endoscopy to EGD (which was transnasal in 11 patients). CONCLUSIONS: Capsule endoscopy was feasible, safe, accurate, highly acceptable, and preferred by cirrhotic patients undergoing screening for portal hypertension. This new technique requires further and more extensive evaluation, as well as assessment of its cost-effectiveness.
机译:背景与研究目的:食管胃十二指肠镜检查(EGD)是检查上消化道特别是评估肝硬化患者门脉高压的最有效方法,尤其是用于筛查目的。这项研究的目的是评估针对该适应症的PillCam ESO胶囊内窥镜检查的可行性,安全性,准确性和耐受性。患者与方法:在这项前瞻性研究中,肝硬化患者在诊断时于同一天进行了未镇静的EGD和胶囊内窥镜检查。患者使用100毫米视觉模拟量表对两种手术的耐受性(相对于疼痛,恶心,窒息感等)进行了量化。记录和胶囊检查诊断所需的时间以及与EGD相比患者的喜好都记录在案。两名对EGD诊断不知情的独立内镜医师评估了所获得图像的诊断准确性。结果:该研究纳入了21名患者(平均年龄62岁,平均终末期肝病模型评分10.5,平均Child-Pugh评分7.3)。该过程是安全的。一名患者无法吞服胶囊。平均记录时间为213 s(范围6-1200 s);该程序准确评估了19例患者中有16例是否存在食管静脉曲张(84.2%);并且正确地表明在100%的病例中需要进行一级预防(2级或以上的食管静脉曲张和/或红色信号)。胶囊内窥镜检查的耐受性明显更好,所有患者均首选胶囊内镜而不是EGD(11例经鼻)。结论:胶囊内窥镜检查是可行,安全,准确,高度可接受的,并且是接受门静脉高压筛查的肝硬化患者的首选。这种新技术需要进一步和更广泛的评估,以及对其成本效益的评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号